Clinical to Population Prevalence of Hypertrophic Cardiomyopathy Phenotype: Insights From the National Echo Database Australia
Journal article
Playford, David, Strange, Geoffrey, Atherton, John, Harris, Sarah Ann, Chan, Yih Kai and Stewart, Simon. (2024). Clinical to Population Prevalence of Hypertrophic Cardiomyopathy Phenotype: Insights From the National Echo Database Australia. Heart Lung and Circulation. 33(2), pp. 212-221. https://doi.org/10.1016/j.hlc.2023.10.021
Authors | Playford, David, Strange, Geoffrey, Atherton, John, Harris, Sarah Ann, Chan, Yih Kai and Stewart, Simon |
---|---|
Abstract | Background: There is a paucity of data describing the underlying prevalence of hypertrophic cardiomyopathy (HCM), a primary genetic disorder characterised by progressive left ventricular (LV) hypertrophy and sudden death, from both a clinical and a population perspective. Methods: We screened the echocardiographic reports of 155,668 men and 147,880 women within the multicentre National Echo Database Australia (NEDA) (2001–2019). End-diastolic wall thickness ≥15 mm anywhere in the left ventricle was identified as a characteristic of an HCM phenotype according to current guideline recommendations. Applying a septal-to-posterior wall thickness ratio >1.3 and LV outflow tract obstruction ≥30 mmHg (when documented), we further identified asymmetric septal hypertrophy and obstructive HCM (oHCM), respectively. The observed pattern of phenotypical HCM within the overall NEDA cohort (>650,000 cases) was then extrapolated to the ∼539,000 (5.7% of adult population) and ∼474,000 (4.8%) Australian men and women, respectively, who were investigated with echocardiography in 2021 on an age-specific basis. Results: Overall, 15,380 cases (mean age 71.1±14.6 years, 10,138 men [65.9%]) with the characteristic HCM phenotype within the NEDA cohort were identified. Of these 15,380 cases, 5,552 (36.1%) had asymmetric septal hypertrophy, and 2,276 of the 10,290 cases with LV outflow tract obstruction profiling data (22.1%) had obstructive HCM. A further 3,389 of 13,715 cases (24.7%) had evidence of LV systolic dysfunction (LV ejection fraction <55%). Within the entire NEDA cohort (including those without LV profiling), HCM was found in 10,138 of 342,161 men (2.96%; 95% confidence interval [CI] 2.91%–3.02%) and 5,242 of 308,539 women (1.70%; 95% CI 1.65%–1.75%). When extrapolated to the Australian population, we estimate that a minimum of 15,971 men and 8,057 women presented with echocardiographic features of phenotypical HCM in 2021. This translates into a minimum caseload/prevalence of ∼17 adult men (∼2.5 in those aged ≤50 years) and eight adult women (∼1 in those aged ≤50 years) per 10,000 population meeting phenotypical HCM criteria. Conclusions: Using contemporary Australian echocardiographic and population data, we estimate that a minimum of 15,971 (17.5 cases/10,000) men and 8,057 women (8.2 cases/10,000) had echocardiographic evidence of phenotypical HCM in 2021. These disease burden data are particularly relevant as new treatment options are emerging. |
Keywords | Hypertrophic cardiomyopathy; Asymmetric septal hypertrophy; Echocardiography; Prevalence |
Year | 01 Jan 2024 |
Journal | Heart Lung and Circulation |
Journal citation | 33 (2), pp. 212-221 |
Publisher | Elsevier Australia |
ISSN | 1328-0163 |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.hlc.2023.10.021 |
Web address (URL) | https://www.sciencedirect.com/science/article/pii/S1443950623044207?via%3Dihub |
Open access | Open access |
Research or scholarly | Research |
Page range | 212-221 |
Publisher's version | License File Access Level Open |
Output status | Published |
Publication dates | |
Online | 03 Jan 2024 |
Publication process dates | |
Accepted | 29 Oct 2023 |
Deposited | 01 Oct 2024 |
Supplemental file | License |
Additional information | © 2023 The Authors. Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) |
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). | |
Place of publication | Australia |
https://acuresearchbank.acu.edu.au/item/90yvw/clinical-to-population-prevalence-of-hypertrophic-cardiomyopathy-phenotype-insights-from-the-national-echo-database-australia
Download files
Publisher's version
OA_Chan_2024_Clinical_to_Population_Prevalence_of_Hypertrophic.pdf | |
License: CC BY 4.0 | |
File access level: Open |
Supplemental file
SM_Chan_2024_Clinical_to_Population_Prevalence_of_Hypertrophic.docx | |
License: CC BY 4.0 |
1
total views0
total downloads1
views this month0
downloads this month